"DNA Mutational Analysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Biochemical identification of mutational changes in a nucleotide sequence.
| Descriptor ID |
D004252
|
| MeSH Number(s) |
E05.393.760.700.300
|
| Concept/Terms |
DNA Mutational Analysis- DNA Mutational Analysis
- Analysis, DNA Mutational
- Analyses, DNA Mutational
- DNA Mutational Analyses
- Mutational Analyses, DNA
- Mutational Analysis, DNA
|
Below are MeSH descriptors whose meaning is more general than "DNA Mutational Analysis".
Below are MeSH descriptors whose meaning is more specific than "DNA Mutational Analysis".
This graph shows the total number of publications written about "DNA Mutational Analysis" by people in this website by year, and whether "DNA Mutational Analysis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 4 | 4 |
| 1998 | 0 | 9 | 9 |
| 1999 | 1 | 10 | 11 |
| 2000 | 0 | 10 | 10 |
| 2001 | 0 | 7 | 7 |
| 2002 | 0 | 10 | 10 |
| 2003 | 0 | 23 | 23 |
| 2004 | 0 | 13 | 13 |
| 2005 | 1 | 22 | 23 |
| 2006 | 0 | 13 | 13 |
| 2007 | 3 | 14 | 17 |
| 2008 | 3 | 16 | 19 |
| 2009 | 1 | 13 | 14 |
| 2010 | 0 | 19 | 19 |
| 2011 | 4 | 11 | 15 |
| 2012 | 3 | 16 | 19 |
| 2013 | 3 | 18 | 21 |
| 2014 | 2 | 14 | 16 |
| 2015 | 2 | 24 | 26 |
| 2016 | 5 | 16 | 21 |
| 2017 | 2 | 11 | 13 |
| 2018 | 2 | 20 | 22 |
| 2019 | 1 | 5 | 6 |
| 2020 | 2 | 6 | 8 |
| 2021 | 2 | 6 | 8 |
| 2022 | 0 | 1 | 1 |
| 2024 | 0 | 2 | 2 |
| 2025 | 0 | 7 | 7 |
| 2026 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "DNA Mutational Analysis" by people in Profiles.
-
Association of genomic driver mutation, histologic subtype, and mTORC1 biomarker expression in mTOR pathway-altered renal tumors. Hum Pathol. 2026 Sep; 175:106154.
-
The impact of next generation sequencing studies on the diagnosis of BAP1 inactivated melanocytic tumors. Hum Pathol. 2026 Jun; 172:106103.
-
A Deeper Dive into POLE -Mutated Endometrial Carcinomas : The Contributions and Consequences of Tumor Mutational Burden. Am J Surg Pathol. 2026 03 01; 50(3):301-312.
-
Mutational signature analysis of chronic lymphocytic leukemia uncovering genomic patterns and prognostic implications. Am J Clin Pathol. 2025 10 04; 164(4):530-544.
-
Improving the diagnosis of leptomeningeal metastases by molecular profiling of cell-free DNA from cerebrospinal fluid. Eur J Cancer. 2025 Oct 16; 229:115783.
-
Renal Tumorigenesis via RAS/RAF/MAPK Pathway Alterations Beyond Papillary Renal Neoplasm With Reverse Polarity. Am J Surg Pathol. 2025 12 01; 49(12):1266-1278.
-
Comparative Molecular Profiling of "Mixed Endometrioid Adenocarcinoma and Adenosarcoma" of the Uterus and Ovary: A Multi-institutional Series of 14 Cases. Am J Surg Pathol. 2025 04 07; 49(8):789-799.
-
Novel Histologic Features in Ameloblastoma With RASQ61R Mutation. Am J Surg Pathol. 2025 05 01; 49(5):508-514.
-
Clinicopathologic and Molecular Characterization of Gynecologic Carcinosarcomas With a Mesonephric-Like Carcinomatous Component. Am J Surg Pathol. 2025 05 01; 49(5):439-447.
-
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix. Proc Natl Acad Sci U S A. 2024 04 23; 121(17):e2321898121.